FinTrust Capital Advisors’s iShares Biotechnology ETF IBB Stock Holding History

FinTrust Capital Advisors’s Portfolio IBB Stock Details IBB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	$188K	Buy	1,291 +900	+230%	+$130K	0.03%	321
2024 Q2	$53.7K	Buy	391 +18	+5%	+$2.4K	0.01%	520
2024 Q1	$51.2K	Hold	373	–	–	0.01%	513
2023 Q4	$50.7K	Hold	373	–	–	0.01%	484
2023 Q3	$45.6K	Sell	373 -106	-22%	-$13.5K	0.01%	475
2023 Q2	$62.9K	Hold	479	–	–	0.02%	413
2023 Q1	$62.9K	Hold	479	–	–	0.02%	411
2022 Q4	$62.9K	Sell	479 -18	-4%	-$2.33K	0.02%	412
2022 Q3	$61K	Buy	497 +18	+4%	+$2.23K	0.02%	470
2022 Q2	$59K	Hold	479	–	–	0.01%	500
2022 Q1	$63K	Hold	479	–	–	0.01%	516
2021 Q4	$73K	Hold	479	–	–	0.02%	485
2021 Q3	$77K	Hold	479	–	–	0.02%	475
2021 Q2	$78K	Buy	479 +13	+3%	+$2K	0.02%	479
2021 Q1	$70K	Buy	466 +93	+25%	+$14.8K	0.02%	482
2020 Q4	$57K	Sell	373 -365	-49%	-$52.2K	0.02%	479
2020 Q3	$100	Hold	738	–	–	0.02%	364
2020 Q2	$101K	Hold	738	–	–	0.04%	325
2020 Q1	$80K	Hold	738	–	–	0.04%	322
2019 Q4	$89K	Hold	738	–	–	0.04%	339
2019 Q3	$73K	Hold	738	–	–	0.02%	386
2019 Q2	$81K	Buy	738 +465	+170%	+$49.5K	0.03%	320
2019 Q1	$31K	Hold	273	–	–	0.01%	491
2018 Q4	$26K	Buy	+273	New	+$29K	0.01%	528

Other funds holding IBB

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Commerce Bank Kansas City, Missouri $20.7B AUM 23.76% 1-Year Est. Return

FinTrust Capital Advisors's IBB Position: Q3 2024 in Review

FinTrust Capital Advisors increased its iShares Biotechnology ETF (IBB) stake by 230% in Q3 2024, buying an estimated $130K and bringing the position to 1,291 shares worth $188K. The position accounts for 0.03% of the portfolio, ranked #321.

FinTrust Capital Advisors first reported a position in IBB in Q4 2018 and has held it in 24 quarters since. 893 funds tracked by Wall St. Rank hold IBB as of Q3 2024.

FinTrust Capital Advisors held 1,291 shares of iShares Biotechnology ETF worth $188K as of Q3 2024.
FinTrust Capital Advisors bought 900 iShares Biotechnology ETF shares in Q3 2024, an estimated $130K.
iShares Biotechnology ETF made up 0.03% of FinTrust Capital Advisors's portfolio in Q3 2024, its #321 holding.
FinTrust Capital Advisors first reported a position in iShares Biotechnology ETF in Q4 2018 and has held it in 24 quarters since.
893 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q3 2024.

Based on FinTrust Capital Advisors's 13F filing for Q3 2024, filed 11 Oct 2024.